
Wednesday, February 02, 2022 9:45:31 AM
New York Yankees and Duke Basketball
Recent JUNS News
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2025 09:08:19 PM
- Jupiter Neurosciences Regains Compliance with Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 07/10/2025 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2025 08:40:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2025 01:28:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2025 01:28:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/04/2025 12:56:52 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/01/2025 11:55:51 PM
- Jupiter Neurosciences Showcases Nugevia™ PWR: Mitochondrial Optimization Supplement Designed to Boost Energy, Endurance, and Recovery • GlobeNewswire Inc. • 06/30/2025 07:15:00 PM
- Jupiter Neurosciences Unveils Nugevia™ GLO: A Breakthrough in Cellular Skin Health, Backed by Patented Pharmaceutical Science • GlobeNewswire Inc. • 06/27/2025 12:00:00 PM
- Jupiter Neurosciences Names Golf Legend Annika Sörenstam as First Nugevia™ Brand Ambassador • GlobeNewswire Inc. • 06/23/2025 12:00:00 PM
- Jupiter Neurosciences Launches Nugevia™: A Premium Longevity and Performance Supplement Line Grounded in Clinical Science • GlobeNewswire Inc. • 06/09/2025 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/21/2025 04:38:15 PM
- Jupiter Neurosciences Highlights Upcoming Milestones in Shareholder Letter • GlobeNewswire Inc. • 04/08/2025 12:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/28/2025 09:01:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2025 09:16:25 PM
- Jupiter Neurosciences and Aquanova AG Announce Strategic Collaboration to Develop Longevity and Healthspan Products • GlobeNewswire Inc. • 03/04/2025 01:00:00 PM
- Jupiter Neurosciences Addresses Market Volatility as it Remains Focused on Advancing Clinical and Commercial Milestones • GlobeNewswire Inc. • 02/04/2025 02:25:00 PM
- Jupiter Neurosciences Announces JOTROL Manufacturing Agreement with Catalent to Support Phase 2a Parkinson’s Trial • GlobeNewswire Inc. • 02/03/2025 01:00:00 PM
- Jupiter Neurosciences Partners with Zina Biopharmaceuticals to Advance Phase 2a Parkinson’s Trial • GlobeNewswire Inc. • 01/30/2025 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2025 07:33:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2025 07:31:28 PM
- Jupiter Neurosciences Announces Strategic Focus on NLRP3 Pathway in Future JOTROL™ Trials • GlobeNewswire Inc. • 01/13/2025 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/23/2024 09:46:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2024 12:00:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2024 10:00:18 PM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM